When the intellectual property heading opens in a due diligence session, what the company presents first is almost invariably the same: a registration schedule, filing dates, a distribution by jurisdiction, perhaps a trademark portfolio table. The reviewing party rarely spends more than a few minutes on that schedule, however, because the operative question arrives at the next step and is usually put in these terms — how much revenue was collected from these rights last year, under which agreement, at what price, and who set the price. The silence that follows that question produces the review's real finding, irrespective of portfolio size. The distance between a right held and the cash collected from it is measured by invoicing practice rather than by certificates of registration, and the two are not substitutes for one another.
The pattern typically observed is this: intellectual property has been positioned inside the company as a legal matter rather than as a commercial one. Patent and trademark filings are managed by counsel or outside agents, renewal calendars are run with discipline, infringement is monitored — yet no written framework governs the conditions under which, and at what consideration, the same right would be opened to a customer, a supplier, or a competitor. The result is an asset that is mature on the defensive side and undefined on the offensive one. That asymmetry is institutionally reasonable, given that the legal function is chartered to reduce risk rather than to increase revenue; but once the condition changes — once the portfolio matures far enough to carry value for third parties — the same configuration obstructs value capture in a systematic way.
The mechanism underlying this tendency is that IP monetization falls within no function's natural remit. The sales team, carrying its quota on product turnover, will comfortably leave a license right on the table as a no-charge addition during negotiation; to that team the right is not a revenue line but a concession that closes the deal. The legal team, responsible for minimizing infringement exposure, tends by default to decline incoming license requests, a refusal that is never recorded as an error against the legal function even though the forgone license revenue is likewise never recorded as a loss anywhere. The product team, treating the technology as part of its own roadmap, naturally resists exposing it externally. Each of the three behaves consistently within its own incentive structure; what is inconsistent is that at the intersection of those three consistencies the monetization decision is never made at all.
What the reviewing party seeks is evidence that this gap has been closed, and the evidence is interrogated across six separate surfaces. The first is existence: whether the monetization model is a stated intention or a constructed structure — that is, whether a decision has been taken as to which channels are open to the company and which are held closed, among licensing, cross-licensing, technology transfer, franchising, know-how sale, and brand usage rights. The second is documentation: whether that decision is written into an approved policy, a standard license template, and a pricing matrix, or resides only in the head of the founder or the general manager. The difference between those two questions is the difference between an asset and an assertion, and an investor does not treat an undocumented practice as verifiable.
The third and fourth surfaces measure the distance between paper and practice. On implementation, the review examines how far executed license agreements deviate from the standard template, on whose authority those deviations were approved, and whether pricing has tracked the matrix; as the deviation rate rises, the inference is that the model has become, in effect, a negotiating habit. On measurement, the questions concern whether IP revenue is tracked as a distinct line item, the number of active licenses, average revenue per license, renewal rate, collection lag, and whether royalty reports are audited. Where those indicators are not maintained, the company does not know how much of its own IP revenue is recurring and how much is non-recurring, and that absence of knowledge feeds directly into the multiple.
The fifth surface is ownership, and in practice it is the most determinative. Where a license request first lands, who sets the price, which discount band is approved at which level, who decides when a dispute arises — absent a written authority matrix, the answer is inevitably a single individual, and that individual is usually the founder. Continuity, the sixth surface, follows directly from that finding: whether the existing IP revenue could be produced without that person. The reviewing party rarely asks this outright; instead it reads the license agreements of the last three years, tracing who conducted the negotiations, through which channel the counterparties arrived, and on what logic the price differentials are explained. An unexplained dispersion in pricing supports the conclusion that the revenue rests on relationships rather than on contracts.
The institutional cost of this deficiency does not appear where most companies expect it. The negotiation does not break on price; it breaks in the representations and warranties section and in the conditions precedent to closing. Where the portfolio has no defined monetization model, the buyer requires an undertaking as to the durability of IP revenues, the company cannot give it, and the outcome is either a higher escrow percentage, an earn-out structure tied to IP revenue, or a closing condition requiring existing license agreements to be re-executed before completion. Each of those three outcomes means, for the seller, that cash is deferred from today into the future. On the valuation side the effect is quieter: undifferentiated IP revenue is priced not at the product-revenue multiple but as a non-recurring item, and in a mid-market transaction that distinction silently erases a visible portion of headline value.
There is a symmetrical cost as well, and it is typically found alongside the first in companies without a monetization model: rights given away unknowingly. Broad usage-right definitions embedded in customer contracts, ownership clauses in joint development protocols, the confidentiality regime governing technical documentation shared with suppliers — none of these are the central subject of a commercial negotiation, so they usually remain inside template language and are never separately priced by anyone. During the review these clauses are read one by one, and every broad grant discovered is recorded as a finding that weakens the exclusivity of the portfolio. The company has transferred, at no consideration, a right it never sold; and it generally learns this at the diligence table.
The mechanism that neutralizes this tendency is institutional architecture rather than individual vigilance. A workable intervention has four separable components. The first is segmentation of the portfolio by business line: which rights protect the core product, which are licensable into adjacent markets, and which are held purely for defensive purposes — three categories whose economic logic differs and which cannot be governed under a single portfolio policy. The second is a pricing framework: floor pricing by channel, volume and exclusivity tiers, and an authority matrix specifying which deviation is approved at which level. The third is the accounting architecture of the revenue: IP income tracked in a dedicated chart-of-accounts line, separated between recurring and non-recurring. The fourth is record discipline: each licensing decision logged together with its rationale at the moment of proposal rather than at the moment of approval.
BEIREK's intervention in this area does not begin with drafting an IP policy document; it begins with a sweep of the existing contract stock. Ownership, usage-right, and invention-assignment clauses are extracted one by one from customer, supplier, joint development, and employment agreements, and converted into a rights inventory setting out which rights have in fact been granted to which parties and at what scope; unlike the registration schedule, that inventory shows the position the company actually retains. Monetization channels are then brought under decision, and for each channel a standard contract template, a floor price band, and a deviation authority matrix are established — the matrix being calibrated less to reduce the founder's approval burden than to ensure that the same price emerges when the founder is absent.
Two rhythms are then run on top of that structure. Monthly, each executed license agreement is reviewed for deviation from the template and the rationale for any deviation is entered into the decision record, so that when the price distribution is questioned a year later, the answer comes from the record rather than from memory. Quarterly, the IP revenue statement — active license count, renewal rate, royalty audit results, collection lag — is consolidated onto a single page and enters the management agenda as a revenue report rather than a legal report. The combined effect of those two rhythms is that, by the time the company enters diligence, the monetization model has ceased to be an assertion and has become an institutional capability supported by three years of record.
The value of a company's IP portfolio accrues not in the number of rights held but in whether the path from those rights to cash can be walked without the founder. Where the portfolio grows while no monetization architecture is built, rights continue to accumulate but value does not; the point at which those two curves diverge is, at the diligence table, usually the place the company has never examined itself. The question worth asking is not how many registrations exist, but who would answer a license request arriving today, at what price, and on the strength of which document.